Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 688.40
-16.70 (-2.37%)
At close: Jan 23, 2026
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 34.92 billion as of January 23, 2026. Its market cap has decreased by -63.16% in one year.
Market Cap
34.92B
Enterprise Value
36.25B
Revenue
8.21B
Ranking
n/a
PE Ratio
66.65
Stock Price
688.40
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 34.92B, an increase of 4,700.32%. That is a compound annual growth rate of 109.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 34.92B | -9.30% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alivus Life Sciences | 105.67B |
| Strides Pharma Science | 76.03B |
| Aarti Pharmalabs | 71.96B |
| Akums Drugs and Pharmaceuticals | 64.26B |
| Sun Pharma Advanced Research Company | 41.80B |
| Innova Captab | 37.15B |
| RPG Life Sciences | 36.45B |
| Solara Active Pharma Sciences | 25.07B |